Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

AC5 improves hair loss and hair quality with high satisfaction rates.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Androgens may influence bladder cancer progression by affecting cellular behavior.

A multimodal treatment approach significantly improved the Labrador's skin condition and itching.

A child with a rare vitamin D-resistant condition improved with treatment.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

MVP treatment is effective and safe for recurrent breast cancer.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The Annurca apple supplement significantly improved hair growth in people with hair loss.

Reporter characteristics affect detection of hair loss from cancer therapy.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

An elderly Chinese man lost all his hair after taking a new heart medication.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Low-coverage sequencing is a cost-effective way to identify genes related to wool traits in rabbits.